Journal profile · Medicine-Transplantation

International Journal of Hematology-Oncology and Stem Cell Research

ISSN 1735-1243 · eISSN 2008-2207 · Tehran University of Medical Sciences · Iran, Islamic Republic of

International Journal of Hematology-Oncology and Stem Cell Research: fully open access; no APC; median 187 days to acceptance (52 articles, last 24 months); indexed in Scopus.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartileQ3Transplantation · rank 39/55 · 30th percentile
Review time187 daysMedian, submission to acceptance · 52 articles, last 24 months · PubMed
APCNo APCFully open access
Acceptance—No reports yet
Articles per year—No count yet

Scope

Aims, scope and focus

International Journal of Hematology-Oncology and Stem Cell Research has been published since 2004, in hematology and oncology domains especially as the only journal in all stem cell transplantation domains with wide distribution. The journal is publishing in English language. The covering topics that the journal would welcome are: Hematology, oncology and stem cell transplantation in all basic and clinical fields. We would be very delighted to receive your original article, review article, commentaries, case report and letter to editor on the above mentioned research fields.

From the journal's Aims & Scope

Research area (LetPub): Medicine-Transplantation

Editor-in-chief Ardeshir GhavamzadehPublisher website

Editorial board by country: none in mainland China; most named Iran 4 (4 members with a country) Editorial board ↗Publisher website ·

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

CiteScore quartiles (Scopus, June 2026 release)

SubjectQuartileRankPercentile
TransplantationQ339/5530th
HematologyQ4117/15122nd
OncologyQ4336/42821st

Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub

Database indexing

ScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
1LetPub ·
CiteScore (publisher) 2025
1Publisher website ·
SJR 2026-06
0.31LetPub ·
SNIP 2026-06
0.4LetPub ·
Share of gold OA articles
0%LetPub ·

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

187 daysMedian, submission to acceptance · P25–P75 109 days – 290 days

Acceptance to online
—
Submission to online
—
Sample
52 articles with submission and acceptance dates (71 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 12 weeksLetPub ·
Peer review
Double anonymous peer reviewLetPub

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessLetPub

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
LetPubNo APCNo—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare5 items from the author guidelines
Abstract
≤ 250 words
Keywords
≥ 3
Reference style
Vancouver
First submission
Free format: the journal's layout is not required
Cover letter
Required
Publisher website · model-extracted, each line checked against the text
Article types accepted5
  1. case reportSevere Toxicodermia due to Apalutamide: A Case Report of DRESS in an Elderly Adult Mónica Fernandes-Pineda , Herney Andres García-Perdomo XML | PDF | downloads:…Length not stated
  2. editorialPost-HSCT COVID-19 Vaccination in Resource-Limited Settings: Why Adaptation Should Not Mean Compromise Maryam Barkhordar XML | PDF | downloads: 82 | views: 193 …Length not stated
  3. letter to editorWe would be very delighted to receive your original article, review article, case report and letter to editor on the above mentioned research fields.Length not stated
  4. original articleRhesus Box as the Primary Mechanism of RHD Gene Deletion in RhD-Negative Blood Donors from Eastern Iran Mobina Nakhaei Shamahmood , Alireza Zangooie , Gholamrez…Length not stated
  5. review articleOutcome of Acute Myeloid Leukemia Treatment and Isocitrate Dehydrogenase (IDH) Mutations: A Systematic Review and Meta-Analysis Study Fereshteh Ameli , Alireza …Length not stated
Publisher website
Policy excerpts from the journal's websitePublication ethics
Publication ethics

Member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE). Model summary

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Tehran University of Medical Sciences
Country or region
Iran, Islamic Republic of
Language
English
ISSN
1735-1243
Print ISSN
2008-3009
Electronic ISSN
2008-2207
Latest issue on the website
Volume 20, Issue 2 (2026)
Official links

FAQ

Frequently asked questions about International Journal of Hematology-Oncology and Stem Cell Research

How long does peer review take at International Journal of Hematology-Oncology and Stem Cell Research?

Based on the dates recorded on 52 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 187 days (interquartile range 109–290 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of International Journal of Hematology-Oncology and Stem Cell Research?

According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 3; Reference style: Vancouver; First submission: Free format: the journal's layout is not required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of International Journal of Hematology-Oncology and Stem Cell Research based?

Of the 4 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Iran (4). Counted from the institutions listed on the board page; for reference only.

Which databases index International Journal of Hematology-Oncology and Stem Cell Research?

According to LetPub and DOAJ records, International Journal of Hematology-Oncology and Stem Cell Research is indexed in Scopus.

Is International Journal of Hematology-Oncology and Stem Cell Research open access, and what is the APC?

International Journal of Hematology-Oncology and Stem Cell Research is a fully open-access journal. It charges no article processing charge.

Sources and updates

The facts on this page come from LetPub, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .